To validate the importance of FOXM1-ANXA2R interactions in glioma pathogenesis, we silenced FOXM1 expression with a FOXM1 specific siRNA (a mixture of four targeting siRNAs). The gene discussed is ANXA2R; the disease is central nervous system cancer.